1.
Hudspeth M, Mori S, Nachbaur D, Perez-Simon JA, Stölzel F, Riches M, Wu W, Zhang P, Agarwal S, Yakoub-Agha I. A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. haematol [Internet]. 2023Apr.1 [cited 2024Apr.19];108(4):1026-38. Available from: https://haematologica.org/article/view/haematol.2022.281471